Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

18.01 USD -0.60 (-3.22%)
Official Closing Price Updated: 4:01 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Angiodynamics Inc

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
ANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at AngioDynamics, Inc. ("AngioDynamics" or the "Company") (NASDAQ: ANGO). 
From PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AngioDynamics, Inc. (ANGO)
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AngioDynamics, Inc. ("AngioDynamics" or the "Company") (NASDAQ: ANGO). Such... 
From PR Newswire
SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc.
Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (Nasdaq:... 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO
Pomerantz LLP is investigating claims on behalf of investors of AngioDynamics, Inc. ("AngioDynamics" or the "Company") (NASDAQ: ANGO). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported fourth quarter... 
From GlobeNewswire News Releases
AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report... 
From GlobeNewswire News Releases
AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology/surgery, today announced the U.S. Food... 
From GlobeNewswire News Releases
AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access
C.R. Bard has illegally tied the sale of its tip location systems to its line of peripherally inserted central catheters (“PICCs”), violating federal antitrust laws, preventing competition in the... 
From GlobeNewswire News Releases
AngioDynamics to Present at the 2017 UBS Global Healthcare Conference
AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael... 
From GlobeNewswire News Releases
AngioDynamics to Present at the 41st Annual Deutsche Bank Health Care Conference
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim... 
From GlobeNewswire News Releases
AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders
AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today... 
From GlobeNewswire News Releases
AngioDynamics Announces Secondary Offering of 2.35 Million Shares of Common Stock by Selling Stockholders
AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today... 
From GlobeNewswire News Releases
AngioDynamics Reports Fiscal 2017 Third Quarter Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial... 
From GlobeNewswire News Releases
AngioDynamics To Host Investor Day on Thursday, April 6, 2017, in New York City
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, will host an Investor Day on... 
From GlobeNewswire News Releases
AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report... 
From GlobeNewswire News Releases
AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology/surgery, today announced it has received... 
From GlobeNewswire News Releases
AngioDynamics to Present at the Barclays Global Healthcare Conference
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of... 
From PR Newswire
AngioDynamics Reports Fiscal 2017 Second Quarter Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial... 
From GlobeNewswire News Releases
AngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim... 
From GlobeNewswire News Releases
AngioDynamics to Report Fiscal 2017 Second Quarter Financial Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
From ACCESSWIRE
AngioDynamics to Participate in Upcoming Investor Conferences
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim... 
From GlobeNewswire News Releases
AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders
AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today... 
From GlobeNewswire News Releases
AngioDynamics Announces Secondary Offering of 2,500,000 Shares of Common Stock by Selling Stockholders
AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today... 
From GlobeNewswire News Releases
AngioDynamics Announces New Senior Credit Facilities and New Share Repurchase Program
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it has... 
From GlobeNewswire News Releases
AngioDynamics Announces Addition of New Board Members: Eileen Auen, Former Executive Chairman of Helios and Jan Stern Reed, Former General Counsel and Corporate Secretary at Walgreens Boots Alliance,
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment... 
From GlobeNewswire News Releases
AngioDynamics to Present at the 2016 Canaccord Genuity Medical Technologies and Diagnostics Forum
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
From ACCESSWIRE
AngioDynamics Reports Fiscal 2017 First Quarter Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported first quarter... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.